RZR-alpha in the Control of Proliferative Vascular Disease [ 2011 - ]

Research Grant

Researchers: Prof Levon Khachigian (Principal investigator) ,  Dr Jianmei Li

Brief description Four million Australians have cardiovascular disease accounting for 35% of all deaths. CVD is the most expensive disease burden and a National Health Priority. Smooth muscle cell growth is a cause of CVD. However, the mechanisms controlling SMC hyperplasia are poorly understood. This project will provide key insights on the role of RZR-alpha in the pathogenesis of blood vessel disease, and develop novel gene-targeting approaches for new opportunities to control complications of CVD.

Funding Amount $521,706.00

Funding Scheme Project Grants

Notes Standard Project Grant